Aspergillus outbreak in an oncology unit: Control measures. Case-control study, and molecular typing

C. L. Thio, D. Smith, G. Bova, C. Cooper, L. Gay, R. Gilpin, W. Merz, C. Miller, T. M. Perl

Research output: Contribution to journalArticle

Abstract

Aspergillus, a ubiquitous fungus, is the leading cause of nosocomial pneumonia in bone marrow transplant (BMT) and leukemic patients undergoing chemotherapy. Our routine surveillance uses standard criteria to define invasive fungal infections (IFI) in BMT and leukemic patients. In 1996, we detected 29 IFI cases, up from 9 in 1995, which were primarily clustered from January to March and September to November. Initial control measures included obtaining monthly air samples, reviewing the ventilation system and physical plant, changing the traffic pattern into the unit, and having patients wear N95 masks outside their rooms. Two of 9 room cultures and no air samples grew Aspergillus flavus (AF). Random amplified polymorphic DNA analysis revealed that one environmental and three patient isolates were identical suggesting a point source. Despite the control measures in place, additional cases developed. We matched 21 culture confirmed or probable (symptoms plus radiologie evidence) invasive AF cases to 20 control subjects without AF to determine risk factors for developing AF. Cases carried the diagnosis of cancer for a longer time (p=0.007, median 69 vs. 509 days) and were clustered on one side of the floor near a stairwell (p=0.054). The length of neutropenia, days of antibiotic therapy or parenteral nutrition, number of radiology visits, and chemotherapy protocol did not differ between the groups (p=NS). In the fall, additional cultures were obtained and 3 of 9 patient room cultures grew AF. Rooms, at patient discharge, were found to be inadequately cleaned, hence housekeeping standards were reinforced and the stairwell near the cluster of cases was closed. These control measures successfully stopped the outbreak. Molecular typing of these patient and room isolates is pending. A multidisciplinary effort is necessary to control aspergillus infections. Molecular typing may be a useful adjunct to determine a point source and to direct control measures.

Original languageEnglish (US)
Number of pages1
JournalClinical Infectious Diseases
Volume25
Issue number2
StatePublished - Dec 1 1997

Fingerprint

Molecular Typing
Aspergillus flavus
Aspergillus
Disease Outbreaks
Case-Control Studies
Patients' Rooms
Bone Marrow
Air
Transplants
Drug Therapy
Housekeeping
Patient Discharge
Parenteral Nutrition
Infection Control
Masks
Neutropenia
Radiology
Ventilation
Pneumonia
Fungi

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Aspergillus outbreak in an oncology unit : Control measures. Case-control study, and molecular typing. / Thio, C. L.; Smith, D.; Bova, G.; Cooper, C.; Gay, L.; Gilpin, R.; Merz, W.; Miller, C.; Perl, T. M.

In: Clinical Infectious Diseases, Vol. 25, No. 2, 01.12.1997.

Research output: Contribution to journalArticle

Thio, CL, Smith, D, Bova, G, Cooper, C, Gay, L, Gilpin, R, Merz, W, Miller, C & Perl, TM 1997, 'Aspergillus outbreak in an oncology unit: Control measures. Case-control study, and molecular typing', Clinical Infectious Diseases, vol. 25, no. 2.
Thio, C. L. ; Smith, D. ; Bova, G. ; Cooper, C. ; Gay, L. ; Gilpin, R. ; Merz, W. ; Miller, C. ; Perl, T. M. / Aspergillus outbreak in an oncology unit : Control measures. Case-control study, and molecular typing. In: Clinical Infectious Diseases. 1997 ; Vol. 25, No. 2.
@article{ccea9317154242af9953c603491155d1,
title = "Aspergillus outbreak in an oncology unit: Control measures. Case-control study, and molecular typing",
abstract = "Aspergillus, a ubiquitous fungus, is the leading cause of nosocomial pneumonia in bone marrow transplant (BMT) and leukemic patients undergoing chemotherapy. Our routine surveillance uses standard criteria to define invasive fungal infections (IFI) in BMT and leukemic patients. In 1996, we detected 29 IFI cases, up from 9 in 1995, which were primarily clustered from January to March and September to November. Initial control measures included obtaining monthly air samples, reviewing the ventilation system and physical plant, changing the traffic pattern into the unit, and having patients wear N95 masks outside their rooms. Two of 9 room cultures and no air samples grew Aspergillus flavus (AF). Random amplified polymorphic DNA analysis revealed that one environmental and three patient isolates were identical suggesting a point source. Despite the control measures in place, additional cases developed. We matched 21 culture confirmed or probable (symptoms plus radiologie evidence) invasive AF cases to 20 control subjects without AF to determine risk factors for developing AF. Cases carried the diagnosis of cancer for a longer time (p=0.007, median 69 vs. 509 days) and were clustered on one side of the floor near a stairwell (p=0.054). The length of neutropenia, days of antibiotic therapy or parenteral nutrition, number of radiology visits, and chemotherapy protocol did not differ between the groups (p=NS). In the fall, additional cultures were obtained and 3 of 9 patient room cultures grew AF. Rooms, at patient discharge, were found to be inadequately cleaned, hence housekeeping standards were reinforced and the stairwell near the cluster of cases was closed. These control measures successfully stopped the outbreak. Molecular typing of these patient and room isolates is pending. A multidisciplinary effort is necessary to control aspergillus infections. Molecular typing may be a useful adjunct to determine a point source and to direct control measures.",
author = "Thio, {C. L.} and D. Smith and G. Bova and C. Cooper and L. Gay and R. Gilpin and W. Merz and C. Miller and Perl, {T. M.}",
year = "1997",
month = "12",
day = "1",
language = "English (US)",
volume = "25",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Aspergillus outbreak in an oncology unit

T2 - Control measures. Case-control study, and molecular typing

AU - Thio, C. L.

AU - Smith, D.

AU - Bova, G.

AU - Cooper, C.

AU - Gay, L.

AU - Gilpin, R.

AU - Merz, W.

AU - Miller, C.

AU - Perl, T. M.

PY - 1997/12/1

Y1 - 1997/12/1

N2 - Aspergillus, a ubiquitous fungus, is the leading cause of nosocomial pneumonia in bone marrow transplant (BMT) and leukemic patients undergoing chemotherapy. Our routine surveillance uses standard criteria to define invasive fungal infections (IFI) in BMT and leukemic patients. In 1996, we detected 29 IFI cases, up from 9 in 1995, which were primarily clustered from January to March and September to November. Initial control measures included obtaining monthly air samples, reviewing the ventilation system and physical plant, changing the traffic pattern into the unit, and having patients wear N95 masks outside their rooms. Two of 9 room cultures and no air samples grew Aspergillus flavus (AF). Random amplified polymorphic DNA analysis revealed that one environmental and three patient isolates were identical suggesting a point source. Despite the control measures in place, additional cases developed. We matched 21 culture confirmed or probable (symptoms plus radiologie evidence) invasive AF cases to 20 control subjects without AF to determine risk factors for developing AF. Cases carried the diagnosis of cancer for a longer time (p=0.007, median 69 vs. 509 days) and were clustered on one side of the floor near a stairwell (p=0.054). The length of neutropenia, days of antibiotic therapy or parenteral nutrition, number of radiology visits, and chemotherapy protocol did not differ between the groups (p=NS). In the fall, additional cultures were obtained and 3 of 9 patient room cultures grew AF. Rooms, at patient discharge, were found to be inadequately cleaned, hence housekeeping standards were reinforced and the stairwell near the cluster of cases was closed. These control measures successfully stopped the outbreak. Molecular typing of these patient and room isolates is pending. A multidisciplinary effort is necessary to control aspergillus infections. Molecular typing may be a useful adjunct to determine a point source and to direct control measures.

AB - Aspergillus, a ubiquitous fungus, is the leading cause of nosocomial pneumonia in bone marrow transplant (BMT) and leukemic patients undergoing chemotherapy. Our routine surveillance uses standard criteria to define invasive fungal infections (IFI) in BMT and leukemic patients. In 1996, we detected 29 IFI cases, up from 9 in 1995, which were primarily clustered from January to March and September to November. Initial control measures included obtaining monthly air samples, reviewing the ventilation system and physical plant, changing the traffic pattern into the unit, and having patients wear N95 masks outside their rooms. Two of 9 room cultures and no air samples grew Aspergillus flavus (AF). Random amplified polymorphic DNA analysis revealed that one environmental and three patient isolates were identical suggesting a point source. Despite the control measures in place, additional cases developed. We matched 21 culture confirmed or probable (symptoms plus radiologie evidence) invasive AF cases to 20 control subjects without AF to determine risk factors for developing AF. Cases carried the diagnosis of cancer for a longer time (p=0.007, median 69 vs. 509 days) and were clustered on one side of the floor near a stairwell (p=0.054). The length of neutropenia, days of antibiotic therapy or parenteral nutrition, number of radiology visits, and chemotherapy protocol did not differ between the groups (p=NS). In the fall, additional cultures were obtained and 3 of 9 patient room cultures grew AF. Rooms, at patient discharge, were found to be inadequately cleaned, hence housekeeping standards were reinforced and the stairwell near the cluster of cases was closed. These control measures successfully stopped the outbreak. Molecular typing of these patient and room isolates is pending. A multidisciplinary effort is necessary to control aspergillus infections. Molecular typing may be a useful adjunct to determine a point source and to direct control measures.

UR - http://www.scopus.com/inward/record.url?scp=33748145607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748145607&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33748145607

VL - 25

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 2

ER -